Koers MDxHealth SA Euronext Bruxelles
Aandelen
MDXH
BE0974461940
Biotechnologie & Medisch Onderzoek
Omzet 2024 * | 78,66 mln. 85,31 mln. | Omzet 2025 * | 89,78 mln. 97,37 mln. | Marktkapitalisatie | 69,2 mln. 75,04 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -26 mln. -28,2 mln. | Nettowinst (verlies) 2025 * | -17 mln. -18,44 mln. | EV/omzet 2024 * | 2,19 x |
Nettoschuld 2024 * | 103 mln. 112 mln. | Nettoschuld 2025 * | 121 mln. 131 mln. | EV/omzet 2025 * | 2,12 x |
K/w-verhouding 2024 * |
-2,73
x | K/w-verhouding 2025 * |
-4,04
x | Werknemers | 300 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 93,92% |
Recentste transcriptie over MDxHealth SA
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 62 | 18-02-19 | |
Ron Kalfus
DFI | Director of Finance/CFO | 50 | 22-07-19 |
Miriam Reyes
COO | Chief Operating Officer | - | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Donnie Hardison
BRD | Director/Board Member | 74 | 29-09-21 |
Eric Bednarski
BRD | Director/Board Member | 52 | 30-07-20 |
Hilde Windels
BRD | Director/Board Member | 59 | 01-11-17 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+43,36% | 54,64 mld. | |
-5,31% | 39,92 mld. | |
+37,52% | 38,82 mld. | |
+14,75% | 26,86 mld. | |
-12,56% | 26,22 mld. | |
-22,45% | 18,78 mld. | |
+0,04% | 12,16 mld. | |
+25,12% | 12,21 mld. | |
+26,04% | 11,94 mld. |